APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine Hydrobromide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Scopolamine Hydrobromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025196 pages

Choose your research edition.

Industry ResearchScopolamine Hydrobromide Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Hydrobromide Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Scopolamine Hydrobromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Hydrobromide Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Hydrobromide Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Scopolamine Hydrobromide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Scopolamine Hydrobromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Scopolamine Hydrobromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Scopolamine Hydrobromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Scopolamine Hydrobromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Scopolamine Hydrobromide include Accord Healthcare, Alchem International, ALKALOIDS CORPORATION, Baxter International, BioCrick, ChemFaces, FUJIFILM Wako, Glentham Life Sciences and Manus Aktteva Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Scopolamine Hydrobromide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Scopolamine Hydrobromide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Scopolamine Hydrobromide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Scopolamine Hydrobromide market size, projected growth trends, production technologies, key applications, and end-use industries.

Scopolamine Hydrobromide Segment by Company

Accord Healthcare

Alchem International

ALKALOIDS CORPORATION

Baxter International

BioCrick

ChemFaces

FUJIFILM Wako

Glentham Life Sciences

Manus Aktteva Biopharma

Sigma-Aldrich

TCI Chemicals

Tocris Bioscience

Amgen

Mylan

Novartis

Sandoz

Teva Pharmaceuticals

Scopolamine Hydrobromide Segment by Type

Injections

Topical

Oral

Scopolamine Hydrobromide Segment by Application

Hospital

Clinic

Scopolamine Hydrobromide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine Hydrobromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine Hydrobromide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine Hydrobromide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Scopolamine Hydrobromide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Scopolamine Hydrobromide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Scopolamine Hydrobromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Scopolamine Hydrobromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Scopolamine Hydrobromide Industry Trends Table 2. Scopolamine Hydrobromide Industry Drivers Table 3. Scopolamine Hydrobromide Industry Opportunities and Challenges Table 4. Scopolamine Hydrobromide Industry Restraints Table 5. Global Scopolamine Hydrobromide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Scopolamine Hydrobromide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Scopolamine Hydrobromide Sales by Manufacturers (Kg) & (2021-2026) Table 8. Global Scopolamine Hydrobromide Sales Market Share by Manufacturers Table 9. Global Scopolamine Hydrobromide Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Scopolamine Hydrobromide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Scopolamine Hydrobromide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Scopolamine Hydrobromide Manufacturers, Product Type & Application Table 13. Global Scopolamine Hydrobromide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Scopolamine Hydrobromide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injections Table 17. Major Manufacturers of Topical Table 18. Major Manufacturers of Oral Table 19. Global Scopolamine Hydrobromide Sales by Type 2021 VS 2025 VS 2032 (Kg) Table 20. Global Scopolamine Hydrobromide Sales by Type (2021-2026) & (Kg) Table 21. Global Scopolamine Hydrobromide Sales by Type (2027-2032) & (Kg) Table 22. Global Scopolamine Hydrobromide Sales Market Share by Type (2021-2026) Table 23. Global Scopolamine Hydrobromide Sales Market Share by Type (2027-2032) Table 24. Global Scopolamine Hydrobromide Revenue by Type 2021 VS 2025 VS 2032 (Kg) Table 25. Global Scopolamine Hydrobromide Revenue by Type (2021-2026) & (Kg) Table 26. Global Scopolamine Hydrobromide Revenue by Type (2027-2032) & (Kg) Table 27. Global Scopolamine Hydrobromide Revenue Market Share by Type (2021-2026) Table 28. Global Scopolamine Hydrobromide Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Global Scopolamine Hydrobromide Sales by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Scopolamine Hydrobromide Sales by Application (2021-2026) & (Kg) Table 33. Global Scopolamine Hydrobromide Sales by Application (2027-2032) & (Kg) Table 34. Global Scopolamine Hydrobromide Sales Market Share by Application (2021-2026) Table 35. Global Scopolamine Hydrobromide Sales Market Share by Application (2027-2032) Table 36. Global Scopolamine Hydrobromide Revenue by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Scopolamine Hydrobromide Revenue by Application (2021-2026) & (Kg) Table 38. Global Scopolamine Hydrobromide Revenue by Application (2027-2032) & (Kg) Table 39. Global Scopolamine Hydrobromide Revenue Market Share by Application (2021-2026) Table 40. Global Scopolamine Hydrobromide Revenue Market Share by Application (2027-2032) Table 41. Global Scopolamine Hydrobromide Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 42. Global Scopolamine Hydrobromide Sales by Region (2021-2026) & (Kg) Table 43. Global Scopolamine Hydrobromide Sales Market Share by Region (2021-2026) Table 44. Global Scopolamine Hydrobromide Sales Forecasted by Region (2027-2032) & (Kg) Table 45. Global Scopolamine Hydrobromide Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 47. North America Scopolamine Hydrobromide Sales by Country (2021-2026) & (Kg) Table 48. North America Scopolamine Hydrobromide Sales by Country (2027-2032) & (Kg) Table 49. Europe Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 50. Europe Scopolamine Hydrobromide Sales by Country (2021-2026) & (Kg) Table 51. Europe Scopolamine Hydrobromide Sales by Country (2027-2032) & (Kg) Table 52. Asia Pacific Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 53. Asia Pacific Scopolamine Hydrobromide Sales by Country (2021-2026) & (Kg) Table 54. Asia Pacific Scopolamine Hydrobromide Sales by Country (2027-2032) & (Kg) Table 55. South America, Middle East and Africa Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 56. South America, Middle East and Africa Scopolamine Hydrobromide Sales by Country (2021-2026) & (Kg) Table 57. South America, Middle East and Africa Scopolamine Hydrobromide Sales by Country (2027-2032) & (Kg) Table 58. Global Scopolamine Hydrobromide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Scopolamine Hydrobromide Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Scopolamine Hydrobromide Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Scopolamine Hydrobromide Revenue Market Share by Region (2021-2026) Table 62. Global Scopolamine Hydrobromide Revenue Market Share by Region (2027-2032) Table 63. Accord Healthcare Company Information Table 64. Accord Healthcare Business Overview Table 65. Accord Healthcare Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Accord Healthcare Scopolamine Hydrobromide Product Portfolio Table 67. Accord Healthcare Recent Development Table 68. Alchem International Company Information Table 69. Alchem International Business Overview Table 70. Alchem International Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alchem International Scopolamine Hydrobromide Product Portfolio Table 72. Alchem International Recent Development Table 73. ALKALOIDS CORPORATION Company Information Table 74. ALKALOIDS CORPORATION Business Overview Table 75. ALKALOIDS CORPORATION Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. ALKALOIDS CORPORATION Scopolamine Hydrobromide Product Portfolio Table 77. ALKALOIDS CORPORATION Recent Development Table 78. Baxter International Company Information Table 79. Baxter International Business Overview Table 80. Baxter International Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Baxter International Scopolamine Hydrobromide Product Portfolio Table 82. Baxter International Recent Development Table 83. BioCrick Company Information Table 84. BioCrick Business Overview Table 85. BioCrick Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. BioCrick Scopolamine Hydrobromide Product Portfolio Table 87. BioCrick Recent Development Table 88. ChemFaces Company Information Table 89. ChemFaces Business Overview Table 90. ChemFaces Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. ChemFaces Scopolamine Hydrobromide Product Portfolio Table 92. ChemFaces Recent Development Table 93. FUJIFILM Wako Company Information Table 94. FUJIFILM Wako Business Overview Table 95. FUJIFILM Wako Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. FUJIFILM Wako Scopolamine Hydrobromide Product Portfolio Table 97. FUJIFILM Wako Recent Development Table 98. Glentham Life Sciences Company Information Table 99. Glentham Life Sciences Business Overview Table 100. Glentham Life Sciences Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Glentham Life Sciences Scopolamine Hydrobromide Product Portfolio Table 102. Glentham Life Sciences Recent Development Table 103. Manus Aktteva Biopharma Company Information Table 104. Manus Aktteva Biopharma Business Overview Table 105. Manus Aktteva Biopharma Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Manus Aktteva Biopharma Scopolamine Hydrobromide Product Portfolio Table 107. Manus Aktteva Biopharma Recent Development Table 108. Sigma-Aldrich Company Information Table 109. Sigma-Aldrich Business Overview Table 110. Sigma-Aldrich Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Sigma-Aldrich Scopolamine Hydrobromide Product Portfolio Table 112. Sigma-Aldrich Recent Development Table 113. TCI Chemicals Company Information Table 114. TCI Chemicals Business Overview Table 115. TCI Chemicals Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. TCI Chemicals Scopolamine Hydrobromide Product Portfolio Table 117. TCI Chemicals Recent Development Table 118. Tocris Bioscience Company Information Table 119. Tocris Bioscience Business Overview Table 120. Tocris Bioscience Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Tocris Bioscience Scopolamine Hydrobromide Product Portfolio Table 122. Tocris Bioscience Recent Development Table 123. Amgen Company Information Table 124. Amgen Business Overview Table 125. Amgen Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Amgen Scopolamine Hydrobromide Product Portfolio Table 127. Amgen Recent Development Table 128. Mylan Company Information Table 129. Mylan Business Overview Table 130. Mylan Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Mylan Scopolamine Hydrobromide Product Portfolio Table 132. Mylan Recent Development Table 133. Novartis Company Information Table 134. Novartis Business Overview Table 135. Novartis Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Novartis Scopolamine Hydrobromide Product Portfolio Table 137. Novartis Recent Development Table 138. Sandoz Company Information Table 139. Sandoz Business Overview Table 140. Sandoz Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Sandoz Scopolamine Hydrobromide Product Portfolio Table 142. Sandoz Recent Development Table 143. Teva Pharmaceuticals Company Information Table 144. Teva Pharmaceuticals Business Overview Table 145. Teva Pharmaceuticals Scopolamine Hydrobromide Sales (Kg), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Teva Pharmaceuticals Scopolamine Hydrobromide Product Portfolio Table 147. Teva Pharmaceuticals Recent Development Table 148. Key Raw Materials Table 149. Raw Materials Key Suppliers Table 150. Scopolamine Hydrobromide Distributors List Table 151. Scopolamine Hydrobromide Customers List Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Scopolamine Hydrobromide Product Image Figure 2. Global Scopolamine Hydrobromide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Hydrobromide Market Size (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Hydrobromide Sales (2021-2032) & (Kg) Figure 5. Global Scopolamine Hydrobromide Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Scopolamine Hydrobromide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injections Image Figure 9. Topical Image Figure 10. Oral Image Figure 11. Global Scopolamine Hydrobromide Sales by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Scopolamine Hydrobromide Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Scopolamine Hydrobromide Sales Market Share by Type (2021-2032) Figure 14. Global Scopolamine Hydrobromide Revenue by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Scopolamine Hydrobromide Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Scopolamine Hydrobromide Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Scopolamine Hydrobromide Sales by Application (2021 VS 2025 VS 2032) & (Kg) Figure 20. Global Scopolamine Hydrobromide Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Scopolamine Hydrobromide Sales Market Share by Application (2021-2032) Figure 22. Global Scopolamine Hydrobromide Revenue by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Scopolamine Hydrobromide Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Scopolamine Hydrobromide Revenue Market Share by Application (2021-2032) Figure 25. North America Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 26. North America Scopolamine Hydrobromide Sales Market Share by Country (2021-2032) Figure 27. U.S. Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 28. Canada Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 29. Mexico Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 30. Europe Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 31. Europe Scopolamine Hydrobromide Sales Market Share by Country (2021-2032) Figure 32. Germany Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 33. France Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 34. U.K. Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 35. Italy Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 36. Netherlands Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 37. Asia Pacific Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 38. Asia Pacific Scopolamine Hydrobromide Sales Market Share by Country (2021-2032) Figure 39. China Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 40. Japan Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 41. South Korea Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 42. Southeast Asia Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 43. India Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 44. Australia Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 45. South America, Middle East and Africa Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 46. South America, Middle East and Africa Scopolamine Hydrobromide Sales Market Share by Country (2021-2032) Figure 47. Brazil Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 48. South Africa Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 49. Saudi Arabia Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 50. Turkey Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 51. Argentina Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 52. UAE Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 53. Egypt Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 54. Chile Scopolamine Hydrobromide Sales and Growth Rate (2021-2032) & (Kg) Figure 55. Global Scopolamine Hydrobromide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Scopolamine Hydrobromide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Scopolamine Hydrobromide Revenue (2021-2032) & (US$ Million) Figure 58. North America Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Scopolamine Hydrobromide Revenue (2021-2032) & (US$ Million) Figure 60. Europe Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Scopolamine Hydrobromide Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Scopolamine Hydrobromide Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Scopolamine Hydrobromide Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Scopolamine Hydrobromide Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Topical
  • Oral
Applications
  • Hospital
  • Clinic
Companies covered
  • Accord Healthcare
  • Alchem International
  • ALKALOIDS CORPORATION
  • Baxter International
  • BioCrick
  • ChemFaces
  • FUJIFILM Wako
  • Glentham Life Sciences
  • Manus Aktteva Biopharma
  • Sigma-Aldrich
  • TCI Chemicals
  • Tocris Bioscience
  • Amgen
  • Mylan
  • Novartis
  • Sandoz
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Scopolamine Hydrobromide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Scopolamine Hydrobromide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Scopolamine Hydrobromide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Scopolamine Hydrobromide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Scopolamine Hydrobromide Market Dynamics
  1. 2.1 Scopolamine Hydrobromide Industry Trends
  2. 2.2 Scopolamine Hydrobromide Industry Drivers
  3. 2.3 Scopolamine Hydrobromide Industry Opportunities and Challenges
  4. 2.4 Scopolamine Hydrobromide Industry Restraints
3 Scopolamine Hydrobromide Market by Manufacturers
  1. 3.1 Global Scopolamine Hydrobromide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Scopolamine Hydrobromide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Scopolamine Hydrobromide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Scopolamine Hydrobromide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Scopolamine Hydrobromide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Scopolamine Hydrobromide Manufacturers, Product Type & Application
  7. 3.7 Global Scopolamine Hydrobromide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Scopolamine Hydrobromide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Scopolamine Hydrobromide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Scopolamine Hydrobromide Tier 1, Tier 2, and Tier 3
4 Scopolamine Hydrobromide Market by Type
  1. 4.1 Scopolamine Hydrobromide Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Topical
  4. 4.1.3 Oral
  5. 4.2 Global Scopolamine Hydrobromide Sales by Type
  6. 4.2.1 Global Scopolamine Hydrobromide Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Scopolamine Hydrobromide Sales by Type (2021-2032)
  8. 4.2.3 Global Scopolamine Hydrobromide Sales Market Share by Type (2021-2032)
  9. 4.3 Global Scopolamine Hydrobromide Revenue by Type
  10. 4.3.1 Global Scopolamine Hydrobromide Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Scopolamine Hydrobromide Revenue by Type (2021-2032)
  12. 4.3.3 Global Scopolamine Hydrobromide Revenue Market Share by Type (2021-2032)
5 Scopolamine Hydrobromide Market by Application
  1. 5.1 Scopolamine Hydrobromide Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Scopolamine Hydrobromide Sales by Application
  5. 5.2.1 Global Scopolamine Hydrobromide Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Scopolamine Hydrobromide Sales by Application (2021-2032)
  7. 5.2.3 Global Scopolamine Hydrobromide Sales Market Share by Application (2021-2032)
  8. 5.3 Global Scopolamine Hydrobromide Revenue by Application
  9. 5.3.1 Global Scopolamine Hydrobromide Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Scopolamine Hydrobromide Revenue by Application (2021-2032)
  11. 5.3.3 Global Scopolamine Hydrobromide Revenue Market Share by Application (2021-2032)
6 Global Scopolamine Hydrobromide Sales by Region
  1. 6.1 Global Scopolamine Hydrobromide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Scopolamine Hydrobromide Sales by Region (2021-2032)
  3. 6.2.1 Global Scopolamine Hydrobromide Sales by Region (2021-2026)
  4. 6.2.2 Global Scopolamine Hydrobromide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Scopolamine Hydrobromide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Scopolamine Hydrobromide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Scopolamine Hydrobromide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Scopolamine Hydrobromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Scopolamine Hydrobromide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Scopolamine Hydrobromide Revenue by Region
  1. 7.1 Global Scopolamine Hydrobromide Revenue by Region
  2. 7.1.1 Global Scopolamine Hydrobromide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Scopolamine Hydrobromide Revenue by Region (2021-2026)
  4. 7.1.3 Global Scopolamine Hydrobromide Revenue by Region (2027-2032)
  5. 7.1.4 Global Scopolamine Hydrobromide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Scopolamine Hydrobromide Revenue (2021-2032)
  8. 7.2.2 North America Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Scopolamine Hydrobromide Revenue (2021-2032)
  11. 7.3.2 Europe Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Scopolamine Hydrobromide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Scopolamine Hydrobromide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Scopolamine Hydrobromide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Accord Healthcare
  2. 8.1.1 Accord Healthcare Company Information
  3. 8.1.2 Accord Healthcare Business Overview
  4. 8.1.3 Accord Healthcare Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Accord Healthcare Scopolamine Hydrobromide Product Portfolio
  6. 8.1.5 Accord Healthcare Recent Developments
  7. 8.2 Alchem International
  8. 8.2.1 Alchem International Company Information
  9. 8.2.2 Alchem International Business Overview
  10. 8.2.3 Alchem International Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alchem International Scopolamine Hydrobromide Product Portfolio
  12. 8.2.5 Alchem International Recent Developments
  13. 8.3 ALKALOIDS CORPORATION
  14. 8.3.1 ALKALOIDS CORPORATION Company Information
  15. 8.3.2 ALKALOIDS CORPORATION Business Overview
  16. 8.3.3 ALKALOIDS CORPORATION Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ALKALOIDS CORPORATION Scopolamine Hydrobromide Product Portfolio
  18. 8.3.5 ALKALOIDS CORPORATION Recent Developments
  19. 8.4 Baxter International
  20. 8.4.1 Baxter International Company Information
  21. 8.4.2 Baxter International Business Overview
  22. 8.4.3 Baxter International Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter International Scopolamine Hydrobromide Product Portfolio
  24. 8.4.5 Baxter International Recent Developments
  25. 8.5 BioCrick
  26. 8.5.1 BioCrick Company Information
  27. 8.5.2 BioCrick Business Overview
  28. 8.5.3 BioCrick Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioCrick Scopolamine Hydrobromide Product Portfolio
  30. 8.5.5 BioCrick Recent Developments
  31. 8.6 ChemFaces
  32. 8.6.1 ChemFaces Company Information
  33. 8.6.2 ChemFaces Business Overview
  34. 8.6.3 ChemFaces Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ChemFaces Scopolamine Hydrobromide Product Portfolio
  36. 8.6.5 ChemFaces Recent Developments
  37. 8.7 FUJIFILM Wako
  38. 8.7.1 FUJIFILM Wako Company Information
  39. 8.7.2 FUJIFILM Wako Business Overview
  40. 8.7.3 FUJIFILM Wako Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 FUJIFILM Wako Scopolamine Hydrobromide Product Portfolio
  42. 8.7.5 FUJIFILM Wako Recent Developments
  43. 8.8 Glentham Life Sciences
  44. 8.8.1 Glentham Life Sciences Company Information
  45. 8.8.2 Glentham Life Sciences Business Overview
  46. 8.8.3 Glentham Life Sciences Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Glentham Life Sciences Scopolamine Hydrobromide Product Portfolio
  48. 8.8.5 Glentham Life Sciences Recent Developments
  49. 8.9 Manus Aktteva Biopharma
  50. 8.9.1 Manus Aktteva Biopharma Company Information
  51. 8.9.2 Manus Aktteva Biopharma Business Overview
  52. 8.9.3 Manus Aktteva Biopharma Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Manus Aktteva Biopharma Scopolamine Hydrobromide Product Portfolio
  54. 8.9.5 Manus Aktteva Biopharma Recent Developments
  55. 8.10 Sigma-Aldrich
  56. 8.10.1 Sigma-Aldrich Company Information
  57. 8.10.2 Sigma-Aldrich Business Overview
  58. 8.10.3 Sigma-Aldrich Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sigma-Aldrich Scopolamine Hydrobromide Product Portfolio
  60. 8.10.5 Sigma-Aldrich Recent Developments
  61. 8.11 TCI Chemicals
  62. 8.11.1 TCI Chemicals Company Information
  63. 8.11.2 TCI Chemicals Business Overview
  64. 8.11.3 TCI Chemicals Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 TCI Chemicals Scopolamine Hydrobromide Product Portfolio
  66. 8.11.5 TCI Chemicals Recent Developments
  67. 8.12 Tocris Bioscience
  68. 8.12.1 Tocris Bioscience Company Information
  69. 8.12.2 Tocris Bioscience Business Overview
  70. 8.12.3 Tocris Bioscience Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Tocris Bioscience Scopolamine Hydrobromide Product Portfolio
  72. 8.12.5 Tocris Bioscience Recent Developments
  73. 8.13 Amgen
  74. 8.13.1 Amgen Company Information
  75. 8.13.2 Amgen Business Overview
  76. 8.13.3 Amgen Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Amgen Scopolamine Hydrobromide Product Portfolio
  78. 8.13.5 Amgen Recent Developments
  79. 8.14 Mylan
  80. 8.14.1 Mylan Company Information
  81. 8.14.2 Mylan Business Overview
  82. 8.14.3 Mylan Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Mylan Scopolamine Hydrobromide Product Portfolio
  84. 8.14.5 Mylan Recent Developments
  85. 8.15 Novartis
  86. 8.15.1 Novartis Company Information
  87. 8.15.2 Novartis Business Overview
  88. 8.15.3 Novartis Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Novartis Scopolamine Hydrobromide Product Portfolio
  90. 8.15.5 Novartis Recent Developments
  91. 8.16 Sandoz
  92. 8.16.1 Sandoz Company Information
  93. 8.16.2 Sandoz Business Overview
  94. 8.16.3 Sandoz Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Sandoz Scopolamine Hydrobromide Product Portfolio
  96. 8.16.5 Sandoz Recent Developments
  97. 8.17 Teva Pharmaceuticals
  98. 8.17.1 Teva Pharmaceuticals Company Information
  99. 8.17.2 Teva Pharmaceuticals Business Overview
  100. 8.17.3 Teva Pharmaceuticals Scopolamine Hydrobromide Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Teva Pharmaceuticals Scopolamine Hydrobromide Product Portfolio
  102. 8.17.5 Teva Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Scopolamine Hydrobromide Value Chain Analysis
  2. 9.1.1 Scopolamine Hydrobromide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Scopolamine Hydrobromide Production Mode & Process
  6. 9.2 Scopolamine Hydrobromide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Scopolamine Hydrobromide Distributors
  9. 9.2.3 Scopolamine Hydrobromide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst